Taysha Gene Therapies

Dallas, United States

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Jun 2026

Post-IPO Equity

Biotechnology Genetics Life Science

Top Investors

Franklin TempletonRA Capital ManagementB CapitalBlackRockSands Capital Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Taysha Gene Therapies

Who are Taysha Gene Therapies's investors?

Taysha Gene Therapies's investors include Franklin Templeton, RA Capital Management, B Capital, BlackRock, Sands Capital Ventures.

Where is Taysha Gene Therapies headquartered?

Taysha Gene Therapies is headquartered in Dallas, United States.

What does Taysha Gene Therapies do?

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

What stage is Taysha Gene Therapies at?

Taysha Gene Therapies is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 24, 2026.

MLA

"Taysha Gene Therapies — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/taysha-gene-therapies. Accessed June 30, 2026.

APA

VCBacked. (2026). Taysha Gene Therapies — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/taysha-gene-therapies

Wikipedia (cite web)

{{cite web |title=Taysha Gene Therapies — Funding & Investors |url=https://www.vcbacked.co/company/taysha-gene-therapies |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 24, 2026.